Skip to content

Study to Evaluate Safety & Effectiveness of Spinal Sealant

A Prospective, Multi-Center, Randomized Controlled Study to Compare the Spinal Sealant System as an Adjunct to Sutured Dural Repair With Standard of Care Methods During Spinal Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00444067
Enrollment
98
Registered
2007-03-07
Start date
2007-05-31
Completion date
2009-08-31
Last updated
2017-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrospinal Fluid Leakage, Subdural

Keywords

Prevention of CSF leak

Brief summary

To evaluate a spinal sealant as an adjunct to sutured dural repair compared to standard of care techniques.

Detailed description

Neurosurgical procedures in the spine often involve incision of the dura mater to access the spinal cord. If the dural incision is not properly repaired and watertight closure is not achieved cerebrospinal fluid (CSF) can escape presenting a risk for significant morbidity. The most frequent complication of CSF leak is recurring headache complicated with symptoms of nausea and vomiting. Furthermore fluid collection under skin prevents proper wound healing and may lead to wound breakdown and infection of the incision or both. Persistent CSF leak has also been associated with the development of cerebellar hemorrhage and subdural hematoma. Primary repair and watertight closure are paramount to minimizing risk and sequelae associated with CSF leak.

Interventions

Spinal Sealant System

OTHERStandard of Care

Standard of Care

Sponsors

Medtronic - MITG
CollaboratorINDUSTRY
Integra LifeSciences Corporation
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Subjects scheduled for a spinal procedure that requires a dural incision

Design outcomes

Primary

MeasureTime frameDescription
Percent(%) Success in Obtaining a Watertight Closure Following Assigned Treatment (Spinal Sealant or Control)Intra-operativePercent(%) success in obtaining a watertight closure following assigned treatment (Spinal Sealant or Control) where success is defined as: A watertight closure of the dural repair intraoperatively after study treatment, confirmed by Valsalva maneuver at 20-25 cm H2O for 5-10 seconds.

Other

MeasureTime frameDescription
Incidence of Post-Operative CSF Leaks90 DaysPercentage of participants with CSF leaks within 90 days post-operatively as determined from clinical diagnosis by one of the following methods: * CSF leak or pseudomeningocele related surgical intervention (i.e., breaking skin) within 90 days post-procedure; or * CSF leak confirmation by diagnostic testing within 90 days post-procedure; or * CSF leak confirmation by clinical evaluation within 90 days post-procedure
Incidence of Post-Operative Surgical Site Infections (SSIs)90 Days•Percentage of participants who incur an SSI within 90 days post-procedure determined by clinical diagnosis SSIs were diagnosed and classified in accordance with the Centers for Disease Control (CDC) criteria for evaluation and diagnosis of nosocomial surgical site infections and were classified as one of the following (Superficial, Deep or Organ/Space).

Countries

United States

Participant flow

Recruitment details

The first subject was consented on May 15, 2007. The last subject visit occurred on August 12, 2009.

Pre-assignment details

Washout study, no run-in or wash-out periods.

Participants by arm

ArmCount
Spinal Sealant
DuraSeal Spinal Sealant System
74
Control
Standard of care methods used as an adjunct to sutured dural repair.
24
Total98

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up01

Baseline characteristics

CharacteristicSpinal SealantControlTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
5 Participants1 Participants6 Participants
Age, Categorical
Between 18 and 65 years
69 Participants23 Participants92 Participants
Age (Statistics)44.25 years
STANDARD_DEVIATION 13.06
44.70 years
STANDARD_DEVIATION 11.44
44.36 years
STANDARD_DEVIATION 12.62
Region of Enrollment
United States
74 participants24 participants98 participants
Sex: Female, Male
Female
30 Participants9 Participants39 Participants
Sex: Female, Male
Male
44 Participants15 Participants59 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
64 / 7320 / 24
serious
Total, serious adverse events
17 / 735 / 24

Outcome results

Primary

Percent(%) Success in Obtaining a Watertight Closure Following Assigned Treatment (Spinal Sealant or Control)

Percent(%) success in obtaining a watertight closure following assigned treatment (Spinal Sealant or Control) where success is defined as: A watertight closure of the dural repair intraoperatively after study treatment, confirmed by Valsalva maneuver at 20-25 cm H2O for 5-10 seconds.

Time frame: Intra-operative

Population: The primary analysis for the primary efficacy endpoint was performed using a two-sided Fisher's Exact Test to test for a difference in the true success rates in obtaining a watertight closure between treatments.

ArmMeasureValue (NUMBER)
Spinal SealantPercent(%) Success in Obtaining a Watertight Closure Following Assigned Treatment (Spinal Sealant or Control)98.0 percentage of participants
ControlPercent(%) Success in Obtaining a Watertight Closure Following Assigned Treatment (Spinal Sealant or Control)79.2 percentage of participants
Other Pre-specified

Incidence of Post-Operative CSF Leaks

Percentage of participants with CSF leaks within 90 days post-operatively as determined from clinical diagnosis by one of the following methods: * CSF leak or pseudomeningocele related surgical intervention (i.e., breaking skin) within 90 days post-procedure; or * CSF leak confirmation by diagnostic testing within 90 days post-procedure; or * CSF leak confirmation by clinical evaluation within 90 days post-procedure

Time frame: 90 Days

Population: Fisher's Exact Test was used to test for a difference in the proportions of subjects with CSF leaks between the two treatments. Confidence intervals were produced based on the observed percentage and also on the percentage estimated using the Kaplan-Meier method.

ArmMeasureValue (NUMBER)
Spinal SealantIncidence of Post-Operative CSF Leaks11 percentage of participants
ControlIncidence of Post-Operative CSF Leaks12.5 percentage of participants
Other Pre-specified

Incidence of Post-Operative Surgical Site Infections (SSIs)

•Percentage of participants who incur an SSI within 90 days post-procedure determined by clinical diagnosis SSIs were diagnosed and classified in accordance with the Centers for Disease Control (CDC) criteria for evaluation and diagnosis of nosocomial surgical site infections and were classified as one of the following (Superficial, Deep or Organ/Space).

Time frame: 90 Days

Population: Fisher's Exact Test was used to test for a difference in the proportions of subjects with SSIs between the two treatments. Confidence intervals were produced based on the observed percentage and also on the percentage estimated using the Kaplan-Meier method.

ArmMeasureValue (NUMBER)
Spinal SealantIncidence of Post-Operative Surgical Site Infections (SSIs)6.8 percentage of participants
ControlIncidence of Post-Operative Surgical Site Infections (SSIs)12.5 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026